Corruption as an Obstacle to Pandemic Response A COVID-19 Case Study
Main Article Content
Abstract
This research explores the relationship between corruption and pandemic outcomes by investigating whether European countries with higher levels of corruption were less successful in fighting COVID-19. Data were analyzed using exploratory factor analysis and structural equation modelling techniques. Results indicate that corruption prevalence and poor bureaucratic quality both decrease trust in government, and this effect is persistent notwithstanding the socioeconomic conditions or geographic attributes of a country. Trust in government, coupled with stringency measures, is positively associated with the number of new people vaccinated, and thus fewer COVID-19-related deaths. Furthermore, corruption undermines trust in the government and its institutions and, through this mechanism, prevents the suppression of the pandemic. Unlike other scarce studies that looked at the direct link between corruption and vaccination only, we also examined the impact of corruption on the outcomes of government pandemic restriction measures and added several contextual variables into the model and found that corruption poses a significant obstacle to pandemic response. Our findings suggest to policymakers that their best weapon against COVID-19 is vaccination, and that renewed efforts to root out corruption and build trust between governments and citizens can positively impact vaccination rates and limit the most devastating effects of the pandemic.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Once the manuscript is accepted for publication, authors shall transfer the copyright to the publisher. If the submitted manuscript is not accepted for printing by the journal, the authors shall retain all their rights. The following rights on the manuscript are transferred to the publisher, including any supplementary materials and any parts, extracts or elements of the manuscript:
- the right to reproduce and distribute the manuscript in printed form, including print-on-demand;
- the right to print prepublications, reprints and special editions of the manuscript;
- the right to translate the manuscript into other languages;
- the right to reproduce the manuscript using photomechanical or similar means including, but not limited to photocopy, and the right to distribute these copies;
- the right to reproduce and distribute the manuscript electronically or optically using and all data carriers or storage media, and especially in machine readable/digitalized form on data carriers such as hard drive, CD-ROM, DVD, Blu-ray Disc (BD), Mini Disc, data tapes, and the right to reproduce and distribute the article via these data carriers;
- the right to store the manuscript in databases, including online databases, as well as the right to transmit the manuscript in all technical systems and modes;
- the right to make the manuscript available to the public or to closed user groups on individual demand, for use on monitors or other readers (including e-books), and in printable form for the user, either via the Internet, online service, or via internal or external networks.
Authors reserve the copyright to published articles and have the right to use the article in the same manner like third parties in accordance with the licence Attribution-Non-Commercial-Non-Derivate 4.0 International (CC BY). Thereby they must quote the basic bibliographic data of the source article published in the journal (authors, article title, journal title, volume, pagination).